Repurposing infectious disease vaccines for intratumoral immunotherapy - CRCL-Ciblage thérapeutique de la tumeur et de son environnement immunitaire Accéder directement au contenu
Article Dans Une Revue Journal for Immunotherapy of Cancer Année : 2019

Repurposing infectious disease vaccines for intratumoral immunotherapy

Résumé

Intratumoral delivery of viruses and virus-associated molecular patterns can achieve antitumor effects that are largely mediated by the elicitation or potentiation of immune responses against the malignancy. Attenuated vaccines are approved and marketed as good manufactiring practice (GMP)-manufactured agents whose administration might be able to induce such effects. Recent reports in mouse transplantable tumor models indicate that the rotavirus, influenza and yellow fever vaccines can be especially suitable to elicit powerful antitumor immunity against cancer following intratumoral administration. These results highlight that intratumoral anti-infectious vaccines can turn cold tumors into hot, and underscore the key role played by virus-induced type I interferon pathways to overcome resistance to immune checkpoint-targeted antibodies.
Fichier principal
Vignette du fichier
e000443.full.pdf (546.63 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03769570 , version 1 (27-02-2024)

Identifiants

Citer

Ignacio Melero, Maria Gato, Tala Shekarian, Angela Aznar, Sandrine Valsesia-Wittmann, et al.. Repurposing infectious disease vaccines for intratumoral immunotherapy. Journal for Immunotherapy of Cancer, 2019, 8 (1), pp.e000443. ⟨10.1136/jitc-2019-000443⟩. ⟨hal-03769570⟩
35 Consultations
4 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More